AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Manual T-piece Versus Ventilator Positive Pressure Ventilation During Resuscitation of Extremely Premature Neonates

RecruitingNAAges 25 Weeks - 29 WeeksAllMichelle Baczynski
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Many extremely premature infants require immediate help with breathing after birth. Positive pressure ventilation (PPV) using a device called a T-piece resuscitator is a common method. PPV is needed to establish proper lung function, improve gas exchange, and encourage the infant to breathe spontaneously. However, T-piece resuscitators have limitations, like a lack of visual feedback and variable settings, which may result in reduced effectiveness of PPV. Improving PPV effectiveness may reduce the need for more invasive procedures, such as intubation, which pose an increased risk of complications and death for these fragile infants. A novel approach, that may overcome the above limitations and deliver PPV with precise settings through a nasal mask, is to use a ventilator to deliver PPV (V-PPV) using a respiratory mode called nasal intermittent positive pressure ventilation (NIPPV). While

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria:: * GA 25+0 to 28+6 weeks using the best available obstetrical estimate * Designated to receive full resuscitation, i.e., not pre-determined to receive only comfort care * Received PPV as determined by the resuscitation team during the first 10 minutes of birth Exclusion Criteria: * Outborn birth status * Resuscitation performed in unforeseen circumstances outside typical delivery room (e.g., emergency department, antenatal ward) * Known major congenital or chromosomal anomaly * Established spontaneous respiration without receipt of PPV
๐Ÿ’Š

What it tests

  • Ventilator derived positive pressure ventilation - V-PPV
  • T-piece resuscitator (TPR)
๐Ÿ“

Where

11 sites
Cedars-Sinai Guerin Children's
Los Angeles, United States
Foothills Medical Centre
Calgary, Canada
Royal Alexandra Hospital
Edmonton, Canada
BC Children's and Women's Hospital
Vancouver, Canada
McMaster Children's Hospital
Hamilton, Canada
Children's Hospital at London Health Sciences Centre
London, Canada
Sunnybrook Health Sciences Centre
Toronto, Canada
Mount Sinai Hospital
Toronto, Canada

โ€ฆand 3 more on ClinicalTrials.gov.

๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy